Skip to content

Clinical trials

Completed Phase 2/3 Anemia, Sickle Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Phase: Phase 2/3 Status: Completed Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20081
20101
20171
20181
20191
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris2
Beni-Suef University1
Indiana University1
Masonic Cancer Center, University of Minnesota1
Medical College of Wisconsin1
University of North Carolina, Chapel Hill1
Vertex Pharmaceuticals Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell8
Vaso-Occlusive Crises2
Acute Chest Syndrome1
Acute Lung Injury1
Anemia, Diamond-Blackfan1
Hematologic Diseases1
Hemoglobinopathies1
Shwachman-Diamond Syndrome1
Thalassemia1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.